Ranitidine and Ledipasvir: Interaction Details

Brand names
Ranitidine
ZantacZantac 75Zantac EFFERdose +2 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Ranitidine

Brand names
  • Zantac
  • Zantac 75
  • Zantac EFFERdose
  • Tritec
  • Ranitidine cool mint

Ledipasvir

We don't have a separate drug information page for Ledipasvir. The FDA's drug directory lists it as part of Harvoni (ledipasvir and sofosbuvir). Read the Ledipasvir and Sofosbuvir drug information page → Have a question about Ledipasvir? Ask a pharmacist, free →

What Happens When You Take Ranitidine With Ledipasvir

What can happen when they are taken together (rated Major)

Decreased ledipasvir exposure and loss of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Caution is warranted when ledipasvir/sofosbuvir is given together with histamine H2 receptor (H2-receptor antagonists), because lower ledipasvir and a loss of efficacy are possible. In drug interaction studies (N=24), simultaneous administration with famotidine reduced ledipasvir by a significant 20%. When cannot be avoided, the H2-receptor antagonist dose should not go above that comparable to famotidine 40 mg twice daily, and it should be taken either at the same time as ledipasvir/sofosbuvir or 12 hours apart.1

The Ranitidine and Ledipasvir Interaction, Explained

Ranitidine lowers stomach acid, and ledipasvir (a hepatitis C medicine) needs some acid to dissolve well. With less acid, your body may absorb a bit less ledipasvir, which could make the hepatitis C treatment work less well. The evidence here is mostly theoretical, based on studies with a similar acid reducer (famotidine) that showed a modest drop in ledipasvir levels.

This does not mean you must avoid both. Your care team can manage it by choosing the right dose and timing. Please check with your pharmacist or doctor before taking any acid reducer with your hepatitis C medicine.

Mechanism: H2-receptor -induced gastric pH elevation reduces ledipasvir solubility and , lowering exposure. Ranitidine data are extrapolated (theoretical); the supporting study used famotidine (N=24), with ledipasvir reduced by about 20%. Onset unspecified.

  • Risk: reduced ledipasvir exposure with possible loss of virologic (rated major).
  • Management: if is required, give the H2RA simultaneously with or 12 hours apart from ledipasvir/sofosbuvir.
  • Do not exceed a dose comparable to famotidine 40 mg twice daily.
  • Monitor treatment response per usual HCV care.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Ranitidine and Ledipasvir Interact

The likely mechanism

Loss of ledipasvir solubility due to increased pH

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Ranitidine and Ledipasvir Interaction

Your care team can usually manage this with careful dosing and timing. Keep taking your medicines as prescribed unless told otherwise.

  • If you need both, the acid reducer is typically taken at the same time as your ledipasvir/sofosbuvir, or 12 hours apart.
  • The acid reducer dose is kept at or below a level comparable to famotidine 40 mg twice daily. Your team may adjust and individualize this.
  • Your team may monitor you more closely during treatment.

Tell your pharmacist or prescriber about all acid or heartburn medicines you use, including over-the-counter ones, so they can help plan timing.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Ranitidine or Ledipasvir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: HARVONI oral tablets, ledipasvir sofosbuvir oral tablets

    Across 2 drug interaction studies (N=24), the of a single dose of ledipasvir 90 mg fell by a significant 20% when it was given at the same time as a single dose of famotidine 40 mg, whereas the reduction in ledipasvir was not significant. When a single dose of famotidine 40 mg was given 12 hours prior to a single dose of ledipasvir 90 mg, ledipasvir Cmax and AUC showed nonsignificant decreases.1

Ranitidine and Ledipasvir: Common Questions

How serious is the Ranitidine and Ledipasvir interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Ranitidine and Ledipasvir interaction managed?

Your care team can usually manage this with careful dosing and timing. Keep taking your medicines as prescribed unless told otherwise. If you need both, the acid reducer is typically taken at the same time as your ledipasvir/sofosbuvir, or 12 hours apart. The acid reducer dose is kept at or below a level comparable to famotidine 40 mg twice daily. Your team may adjust and individualize this. Your… Management is individual — always follow your own care team's guidance.

How far apart should I take Ranitidine and Ledipasvir?

The interaction record says to take ranitidine and ledipasvir 12 hours apart.

Your pharmacist can help you fit this into the times you take your other medicines.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Ranitidine and Ledipasvir Interaction

Ask in your own words about taking Ranitidine and Ledipasvir together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: HARVONI(R) oral tablets, ledipasvir sofosbuvir oral tablets. Gilead Sciences, Inc. (per manufacturer), Foster City, CA, 2014. DailyMed
Was this write-up helpful?

Other Serious Interactions of Ranitidine and Ledipasvir

Also serious with Ranitidine

Also serious with Ledipasvir

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Ranitidine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.